跳转至内容
Merck
CN

[Short-course chemotherapy of tuberculosis with pyrazinamide].

Nihon rinsho. Japanese journal of clinical medicine (1999-01-12)
S Asai, Y Futsuki, S Tomari, J Araki
摘要

A 6-month regimen consisting of isoniazid (INH. 0.3-0.5 g).rifampicin (RFP. 0.3-0.45 g).pyrazinamide (PZA. 1.2-2.0 g) and streptomycin (SM. 0.75 g) or ethambutol (EB. 0.75-1.0 g) given for 2 month followed by isoniazid and rifampicin for 4 month is the preferred treatment for patients with fully susceptible organism, who adhere to treatment. Consideration should be given to treating all patients with directly observed treatment.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
格列吡嗪
吡嗪酰胺, European Pharmacopoeia (EP) Reference Standard